White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 273 participants.
Also called NCT01758601
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 273 participants
- Registry
-
NCT01758601
-
- Other papers using this trial's data
- White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT01758601. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study
- Condition
- Cardiovascular Risk Factors
- Condition
- Metabolic Syndrome
- Intervention (Other)
- Dietary intervention with 7 servings oh white fish per week (each serve consisted of 100g of frozen Namibia hake, Pescanova S.A., Pontevedra, Spain)
- Intervention (Other)
- Previous alimentary habits, avoiding any significant nutritional imbalance, as well as any fish or seafood
- Lead sponsor
- Hospital Universitario Ramon y Cajal
- Collaborator
- CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn).
- Collaborator
- Pescanova S.A., Pontevedra, Spain.
Record details
- Record id
cardio:ct-nct01758601- Content hash
ee46fe56d7eb6c2bde6b22a6ae5d1beb308d04b00ae1c8314c52f575e1d88dc0